Tissue-Specific Infection by Group A Streptococci
A 组链球菌引起的组织特异性感染
基本信息
- 批准号:7623275
- 负责人:
- 金额:$ 41.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAffectAllelesBiologicalCarrier StateDefectDiseaseEpithelialEpithelial CellsGene ExpressionGene TargetingGenesGenetic TranscriptionGenomeGenotypeGeographic DistributionGoalsHumanImpetigoInfectionInvasiveKnowledgeMediatingMolecularMorbidity - disease rateOrganismPathway interactionsPharyngeal structurePharyngitisPilumPopulationPrincipal InvestigatorProcessProductionProphylactic treatmentProteinsRangeRegulationRegulonRheumatic Heart DiseaseRoleSiteSkinStreptococcus pyogenesSurfaceTestingTissuesToxic Shock SyndromeViral Tumor AntigensVirulenceabstractingmortalitypilus genespreferenceprogramsresponsesialosyl-T antigentransmission process
项目摘要
Project Summary/Abstract.
Group A streptococci (GAS; Streptococcus pyogenes) are remarkable for the wide range of diseases they
cause in humans, their sole biological host. Yet, most infections are mild and involve one of two tissues - the
epithelial surface of the throat or skin - giving rise to pharyngitis or impetigo, respectively. A long-term goal is to
better understand the distinct pathogenic mechanisms leading to pharyngitis and impetigo. A primary focus of
the proposal is the regulation of pili expression in GAS.
Pilus-associated proteins mediate adherence to epithelial cells and enhance superficial infection at the skin.
Pili correspond to the T-antigens of GAS. All strains examined have pilus genes, however, many natural GAS
isolates lack T-antigen. The hypothesis to be tested in Aim 1 states that organisms recovered from a carrier
state and/or invasive disease are significantly more likely to have defects in pilus production, as compared to
isolates derived from cases of pharyngitis or impetigo. Aim 1 seeks to define the relationship between defects
in pilus expression and disease. The nra/rofA locus encodes a ¿stand alone¿ response regulator that affects the
transcription of pilus genes; nra and rofA denote discrete lineages of alleles. Both Nra and RofA can have
positive or negative regulatory effects on pilus gene transcription, depending on the GAS isolate or strain. The
hypothesis to be tested in Aim 2 states that there are strain-specific differences among modulators of pilus
gene expression that lie in a pathway upstream of Nra/RofA. Aim 2 seeks to identify regulators of pilus gene
transcription having a differential presence among strains. The distribution of Nra and RofA among GAS is
strongly correlated with subpopulations of strains having a tendency to cause infection at either the throat or
skin. Nra and RofA are global regulators of GAS gene transcription. Two hypotheses will be addressed in Aim
3: (i), that co-regulated non-pilus genes act in concert with pili to cause disease; and (ii), that Nra and RofA
confer differential transcription of downstream genes. Aim 3 seeks to identify genes of the Nra and RofA
regulons, and to test their role in virulence.
Through a better understanding of the molecular mechanisms used by GAS to persist in their primary
ecological niches - the throat and skin of the human host - will come new knowledge on how best to interfere
with these vital processes. Effective control and prevention measures that disrupt the chain of transmission of
GAS will result in a decreased burden of the more severe GAS diseases (toxic shock syndrome, rheumatic
heart disease) which have a high morbidity and mortality for many people throughout the world.
项目概要/摘要。
A组链球菌(GAS;化脓性链球菌)因其广泛的疾病而引人注目,
因为人类是它们唯一的生物宿主。然而,大多数感染是温和的,涉及两种组织之一-
咽喉或皮肤的上皮表面-分别引起咽炎或脓疱。长期目标是
更好地了解导致咽炎和脓疱的不同致病机制。的主要焦点
该建议是GAS中皮利表达的调节。
菌毛相关蛋白介导对上皮细胞的粘附并增强皮肤的浅表感染。
皮利对应于GAS的T抗原。所有检测的菌株都有菌毛基因,然而,许多天然GAS
分离物缺乏T抗原。目标1中有待检验的假设指出,从载体中回收的微生物
状态和/或侵入性疾病更可能具有菌毛产生缺陷,
分离自咽炎或脓疱病病例。目标1旨在定义缺陷之间的关系
在菌毛表达和疾病中。nra/rofA基因座编码一个独立的反应调节因子,
菌毛基因的转录; nra和rofA表示等位基因的离散谱系。NRA和RofA都可以拥有
对菌毛基因转录的正或负调节作用,取决于GAS分离株或菌株。的
目标2中待检验的假设指出,菌毛调节剂之间存在菌株特异性差异
位于Nra/RofA上游途径的基因表达。目的2旨在鉴定菌毛基因的调节因子
在不同的菌株之间有差异的转录。Nra和RofA在GAS中的分布为:
与倾向于在咽喉或咽喉部引起感染的菌株亚群密切相关,
皮肤Nra和RofA是GAS基因转录的全局调节因子。两个假设将在Aim中讨论
3:(i),共调节的非菌毛基因与皮利协同作用引起疾病;和(ii),Nra和RofA
赋予下游基因的差异转录。目的3旨在确定Nra和RofA的基因
调节子,并测试其在毒性中的作用。
通过更好地理解GAS用于坚持其主要功能的分子机制,
生态位--人类宿主的喉咙和皮肤--将带来关于如何最好地干预的新知识。
这些重要的过程。采取有效的控制和预防措施,破坏病毒的传播链
GAS将导致更严重的GAS疾病(中毒性休克综合征、风湿性关节炎、呼吸道感染)的负担降低。
心脏病),其对于全世界许多人具有高发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Debra E BESSEN其他文献
Debra E BESSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Debra E BESSEN', 18)}}的其他基金
Protective antibody in streptococcal infection models
链球菌感染模型中的保护性抗体
- 批准号:
10576491 - 财政年份:2022
- 资助金额:
$ 41.35万 - 项目类别:
Macrolide resistance transfer in Streptococcus pyogenes
化脓性链球菌中的大环内酯类耐药性转移
- 批准号:
10474268 - 财政年份:2021
- 资助金额:
$ 41.35万 - 项目类别:
Pilin Genotyping for Group A Streptococci
A 组链球菌的 Pilin 基因分型
- 批准号:
10056809 - 财政年份:2020
- 资助金额:
$ 41.35万 - 项目类别:
Pilin Genotyping for Group A Streptococci
A 组链球菌的 Pilin 基因分型
- 批准号:
10171765 - 财政年份:2020
- 资助金额:
$ 41.35万 - 项目类别:
Population analysis of group A streptococcal phenotypes
A 组链球菌表型的群体分析
- 批准号:
9035797 - 财政年份:2015
- 资助金额:
$ 41.35万 - 项目类别:
Population analysis of group A streptococcal phenotypes
A 组链球菌表型的群体分析
- 批准号:
9196327 - 财政年份:2015
- 资助金额:
$ 41.35万 - 项目类别:
Tissue-Specific Infection by Group A Streptococci
A 组链球菌的组织特异性感染
- 批准号:
7872639 - 财政年份:2009
- 资助金额:
$ 41.35万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Fellowship Programs